(19)
(11) EP 3 525 798 A1

(12)

(43) Date of publication:
21.08.2019 Bulletin 2019/34

(21) Application number: 17861108.3

(22) Date of filing: 12.10.2017
(51) International Patent Classification (IPC): 
A61K 31/7105(2006.01)
A61K 39/395(2006.01)
A61K 48/00(2006.01)
A61K 39/00(2006.01)
A61K 45/00(2006.01)
A61P 7/00(2006.01)
(86) International application number:
PCT/US2017/056386
(87) International publication number:
WO 2018/071701 (19.04.2018 Gazette 2018/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 13.10.2016 US 201662407979 P
05.01.2017 US 201715399524
27.03.2017 US 201715470647
30.06.2017 US 201762527926 P

(71) Applicants:
  • University Of Leicester
    Leicester, Leicestershire LE1 7RH (GB)
  • Omeros Corporation
    Seattle, WA 98119 (US)

(72) Inventors:
  • BRUNSKILL, Nigel, John
    Mountsorrel LE12 7AF (GB)
  • DEMOPULOS, Gregory, A.
    Mountsorrel LE12 7AF (US)
  • DUDLER, Tom
    Mountsorrel LE12 7AF (US)
  • SCHWAEBLE, Hans-Wilhelm
    Mountsorrel LE12 7AF (GB)

(74) Representative: Avidity IP 
Broers Building Hauser Forum 21 JJ Thomson Avenue
Cambridge CB3 0FA
Cambridge CB3 0FA (GB)

   


(54) METHODS FOR REDUCING PROTEINURIA IN A HUMAN SUBJECT SUFFERING FROM IMMUNOGLOBULIN A NEPHROPATHY